This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Elsevier Launches New Open Access Journal: Translational Proteomics

GENEVA, Switzerland, May 27, 2013 /PRNewswire/ --

First articles now available online on ScienceDirect

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of Translational Proteomics, an online-only, open access journal devoted to transferring fundamental discoveries in the field of proteomics to clinical applications, accelerating understanding and treatment of human diseases.

Jean-Charles Sanchez, Associate Professor at the University of Geneva, Head of the Biomedical Research Proteomics Group and Director of the Proteomics Core Facility of the Faculty of Medicine, will serve as Editor-in-Chief. The journal aims to cover all areas of research in human proteomics using multi-disciplinary approaches to untangle complex disease processes, such as oncology, neurology, immunology, cardiovascular diseases, infectious diseases and any internal medical disorder. Special sections within the journal will highlight research in areas like systems biology and integrative bioinformatics, clinical proteomics and personalized medicine, comparative proteomics and drug development, medical bioinformatics and biostatistics, food and health.

"With the launch of Translational Proteomics, we want to help the scientific and medical communities overcome the challenges they face on the long path from basic research to patient care," said Professor Sanchez. "By focusing on connecting basic proteomics research to ultimate clinical applications, the journal will provide a space for publications detailing proteomics experiments, from early discovery to validation and the bedside."

"We are excited about the launch of Translational Proteomics", added Dolors Alsina, Executive Publisher at Elsevier. "This journal provides a unique platform for the publication of high-quality, multi-disciplinary studies, combining research which, until now, would have been broken into two or more specialized publications."

For more information or to submit an article, visit http://www.elsevier.com/locate/trprot

Open Access Publishing at Elsevier

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,066.27 -55.74 -0.33%
S&P 500 1,995.66 -4.46 -0.22%
NASDAQ 4,559.1470 -10.4740 -0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs